As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Donald Trump returned to the US presidency on January 20 with a flurry of executive orders. This included the designation of ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...

President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug ...

An executive order designating cartels as terrorist organizations will expand prosecutors' jurisdictions, affect relations ...

These stocks have climbed more than 80% and 200% over the past three years. But demand for their products and potential ...

Aardvark Therapeutics files for IPO. Company develops hunger-targeting obesity drug ARD-101 and ARD-201, led by CEO Tien Lee.

Former New York Giants safety Jabrill Peppers has pleaded guilty to a drug charge dating back to an October domestic violence case.

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...

WASHINGTON U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Senator Chuck Grassley (R-IA), senior member and former ...